Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Related Citations for PubMed (Select 16278853)

1.

APOE epsilon4 is not associated with Alzheimer's disease in elderly Nigerians.

Gureje O, Ogunniyi A, Baiyewu O, Price B, Unverzagt FW, Evans RM, Smith-Gamble V, Lane KA, Gao S, Hall KS, Hendrie HC, Murrell JR.

Ann Neurol. 2006 Jan;59(1):182-5.

2.

Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba.

Hall K, Murrell J, Ogunniyi A, Deeg M, Baiyewu O, Gao S, Gureje O, Dickens J, Evans R, Smith-Gamble V, Unverzagt FW, Shen J, Hendrie H.

Neurology. 2006 Jan 24;66(2):223-7.

3.

[Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].

Rosich-Estragó M, Figuera-Terré L, Mulet-Pérez B, Arrufat-Cardús MT, Pascual San Emeterio A, Arbeola-Rigau I, Labad-Alquézar A, Vilella-Cuadrada E.

Rev Neurol. 2004 May 1-15;38(9):801-7. Spanish.

4.

Lack of an association between apolipoprotein E epsilon 4 and Alzheimer's disease in elderly Nigerians.

Osuntokun BO, Sahota A, Ogunniyi AO, Gureje O, Baiyewu O, Adeyinka A, Oluwole SO, Komolafe O, Hall KS, Unverzagt FW, et al.

Ann Neurol. 1995 Sep;38(3):463-5.

PMID:
7668835
5.

Epidemiology of dementia in Nigeria: results from the Indianapolis-Ibadan study.

Ogunniyi A, Baiyewu O, Gureje O, Hall KS, Unverzagt F, Siu SH, Gao S, Farlow M, Oluwole OS, Komolafe O, Hendrie HC.

Eur J Neurol. 2000 Sep;7(5):485-90.

PMID:
11054131
6.

Association of apolipoprotein E polymorphism in late-onset Alzheimer's disease and vascular dementia in Brazilians.

Souza DR, de Godoy MR, Hotta J, Tajara EH, Brandão AC, Pinheiro Júnior S, Tognola WA, dos Santos JE.

Braz J Med Biol Res. 2003 Jul;36(7):919-23. Epub 2003 Jun 26.

7.

Apolipoprotein E genotypes and the incidence of Alzheimer's disease among persons aged 75 years and older: variation by use of antihypertensive medication?

Guo Z, Fratiglioni L, Viitanen M, Lannfelt L, Basun H, Fastbom J, Winblad B.

Am J Epidemiol. 2001 Feb 1;153(3):225-31.

8.

Relation of apolipoprotein E polymorphism to clinically diagnosed Alzheimer's disease in the Korean population.

Kim HC, Kim DK, Choi IJ, Kang KH, Yi SD, Park J, Park YN.

Psychiatry Clin Neurosci. 2001 Apr;55(2):115-20.

PMID:
11285089
9.

Apolipoprotein E polymorphism in elderly Chilean people with Alzheimer's disease.

Quiroga P, Calvo C, Albala C, Urquidi J, Santos JL, Pérez H, Klaassen G.

Neuroepidemiology. 1999;18(1):48-52.

PMID:
9831815
10.

APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.

Klages JD, Fisk JD, Rockwood K.

Dement Geriatr Cogn Disord. 2003;15(1):1-5.

PMID:
12457072
12.

Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease.

Mayeux R, Saunders AM, Shea S, Mirra S, Evans D, Roses AD, Hyman BT, Crain B, Tang MX, Phelps CH.

N Engl J Med. 1998 Feb 19;338(8):506-11. Erratum in: N Engl J Med 1998 Apr 30;338(18):1325.

13.

Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.

Myers RH, Schaefer EJ, Wilson PW, D'Agostino R, Ordovas JM, Espino A, Au R, White RF, Knoefel JE, Cobb JL, McNulty KA, Beiser A, Wolf PA.

Neurology. 1996 Mar;46(3):673-7.

PMID:
8618665
14.

Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: variation by age and sex.

Qiu C, Kivipelto M, Agüero-Torres H, Winblad B, Fratiglioni L.

J Neurol Neurosurg Psychiatry. 2004 Jun;75(6):828-33.

15.

Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.

Raygani AV, Zahrai M, Raygani AV, Doosti M, Javadi E, Rezaei M, Pourmotabbed T.

Neurosci Lett. 2005 Feb 25;375(1):1-6. Epub 2004 Nov 26.

PMID:
15664112
16.

Association of apolipoprotein E genotype and Alzheimer disease in African Americans.

Murrell JR, Price B, Lane KA, Baiyewu O, Gureje O, Ogunniyi A, Unverzagt FW, Smith-Gamble V, Gao S, Hendrie HC, Hall KS.

Arch Neurol. 2006 Mar;63(3):431-4.

17.

APOE alleles in Alzheimer's disease and vascular dementia in a population aged 85+.

Sulkava R, Kainulainen K, Verkkoniemi A, Niinistö L, Sobel E, Davanipour Z, Polvikoski T, Haltia M, Kontula K.

Neurobiol Aging. 1996 May-Jun;17(3):373-6.

PMID:
8725898
18.

Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.

Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN.

Am J Pathol. 1996 Jun;148(6):2083-95.

19.

Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study.

McCusker SM, Curran MD, Dynan KB, McCullagh CD, Urquhart DD, Middleton D, Patterson CC, McIlroy SP, Passmore AP.

Lancet. 2001 Feb 10;357(9254):436-9.

PMID:
11273064
20.

Single photon emission computed tomography and apolipoprotein E in Alzheimer's disease: impact of the epsilon4 allele on regional cerebral blood flow.

Høgh P, Knudsen GM, Kjaer KH, Jørgensen OS, Paulson OB, Waldemar G.

J Geriatr Psychiatry Neurol. 2001 Spring;14(1):42-51.

PMID:
11281316
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk